Testing a cervical biopsy for uterine masses
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests whether a needle biopsy through the cervix (transcervical true-cut biopsy) can accurately diagnose uterine masses before surgery. It might help women avoid a more invasive procedure if the biopsy shows a non-cancerous mass.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a uterine mass seen on imaging that needs surgical removal.
- You are not a virgin (the biopsy is done through the cervix).
- You do not have an active genital tract infection.
- You do not have a bleeding disorder or take uncorrected blood thinners.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well an ultrasound-guided needle biopsy (Tru-Cut) can safely collect tissue samples from pelvic masses. It may help doctors confirm diagnoses and guide treatment by improving how biopsies are done in real-world care.
This trial uses a special needle (TRU-Cut biopsy) to take a small tissue sample from a tumor in your abdomen or pelvis. The goal is to better understand the type of cancer and help guide your treatment.
This trial tests whether a special biopsy (called a tru-cut biopsy) can help doctors better understand and manage unusual growths in the uterus that look like fibroids but may not be typical. It is for women who are already planning to have surgery for such a growth.
This trial tests a new ultrasound-guided biopsy technique through the vagina to get tissue samples from uterine fibroids or smooth muscle tumors. It aims to see if this method is safer and more accurate than standard approaches.
This study tests a new way to take a small tissue sample from uterine fibroids using ultrasound guidance through the vagina. It aims to see if this method is safe and effective for diagnosing fibroid tumors before surgery.
This study tests a simple, non-invasive method to detect endometrial cancer in women after menopause who have abnormal bleeding. It aims to find cancer early in those at higher risk, such as women with certain genetic conditions or risk factors.
Hear when a new Uterine Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.